Pregnancy and herpes genitalis – a diagnostic and therapeutic challenge
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2010, Vol 27, Issue 6
Abstract
Genital herpes, an infection with the herpes simplex virus (HSV-1 or HSV-2), constitutes one of the most common sexually transmitted viral diseases worldwide. The primary problem of such an infection during pregnancy is transmission of the virus to the fetus or the newborn infant, with subsequent serious neonatal symptoms. Following sexual transmission of HSV-2 and after an incubation period of 4−5 days, typical dermatological changes in the genital region occur, which evolve into painful pustules. The diagnosis is based on the clinical symptoms and characteristic dermatological lesions. A course of suppressive treatment with acyclovir from the 36th week of gestation decreases considerably the symptomatology and the relapse frequency of a herpes genitalis. A cesarean section should be performed in patients with clinical symptomatology and active herpes genitalis infection, at the latest within 4−6 hours of rupture of fetal membranes. Despite these prophylactic measures, vertical transmission of genital herpes to the baby cannot be entirely excluded.
Authors and Affiliations
I. MYLONAS, K. FRIESE
Keywords
Related Articles
- EP ID EP102567
- DOI -
- Views 65
- Downloads 0
Idiopathic CD4+ lymphocytopenia in a patient with Sjogren's syndrome
No abstract available
Ασθενής με χρόνια λήψη κορτικοειδών<br /> και παρατεινόμενο εμπύρετο νόσημα
Η σπλαγχνική λεϊσμανίαση ή καλααζάρ είναι λοιμώδης νόσος, η οποία οφείλεται σε μαστιγοφόρα πρωτόζωα που ανήκουν στο γένος Leishmania. Υπάρχει δυσκολία για τον καθορισμό των ειδών των λεϊσμανιών, επειδή όλα τα είδη έχ...
Παράγωγα της λέξης αίμα στην Αγγλική γλώσσα
Role of incretin, incretin analogues and dipeptidyl peptidase 4 inhibitors<br /> in the pathogenesis and treatment of diabetes mellitus
Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gut-derived incretin hormones that stimulate insulin and suppress glucagon secretion, inhibit gastric emptying, and reduce appeti...
Tyrosine kinase inhibitor –<br /> a new targeted therapy for chronic myeloid leukemia
The treatment of patients with Ph(+) or BCR-ABL(+) chronic myeloid leukemia (CML) did not improve very greatly in the 1990s. It is now widely accepted that patients treated by allogeneic stem cell transplantation may be...